Fibrotic remodeling and tissue regeneration mechanisms define the therapeutic potential of human muscular progenitors
Bioengineering & Translational Medicine · 2023-03 · 8 (2)
DOI: 10.1002/btm2.10439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 26.11.2022. Verfasst von Ya-Chuan Hsiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology Taipei City Hospital, Zhongxing Branch Taipei Taiwan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, National Taiwan University Hospital.
Abstract (Originalsprache)
Fibrosis is an intrinsic biological reaction toward the challenges of tissue injury that is implicated in the wound‐healing process. Although it is useful to efficiently mitigate the damage, progression of fibrosis is responsible for the morbidity and mortality occurring in a variety of diseases. Because of lacking effective treatments, there is an emerging need for exploring antifibrotic strategies. Cell therapy based on stem/progenitor cells is regarded as a promising approach for treating fibrotic diseases. Appropriate selection of cellular sources is required for beneficial results. Muscle precursor cells (MPCs) are specialized progenitors harvested from skeletal muscle for conducting muscle regeneration. Whether they are also effective in regulating fibrosis has seldom been explored and merits further investigation. MPCs were successfully harvested from all human samples regardless of demographic backgrounds. The extracellular matrices remodeling was enhanced through the paracrine effects mediated by MPCs. The suppression effects on fibrosis were confirmed in vivo when MPCs were transplanted into the diseased animals with oral submucous fibrosis. The data shown here revealed the potential of MPCs to be employed to simultaneously regulate both processes of fibrosis and tissue regeneration, supporting them as the promising cell candidates for development of the cell therapy for antifibrosis and tissue regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology Taipei City Hospital, Zhongxing Branch Taipei Taiwan.
- Department of Ophthalmology College of Medicine, National Yang Ming Chiao Tung University Taipei Taiwan.
- Department of Otolaryngology National Taiwan University Hospital and College of Medicine Taipei Taiwan.
- Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University Taipei Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University Taipei Taiwan.
ORCID-Profile: Tsung-Lin Yang
Förderung
- Ministry of Science and Technology
- National Taiwan University Hospital
Zitieren
APA
Hsiao, Y. C., Wang, I. H., & Yang, T. L. (2023). Fibrotic remodeling and tissue regeneration mechanisms define the therapeutic potential of human muscular progenitors. Bioengineering & Translational Medicine, 8(2). https://doi.org/10.1002/btm2.10439
Vancouver
Hsiao YC, Wang IH, Yang TL. Fibrotic remodeling and tissue regeneration mechanisms define the therapeutic potential of human muscular progenitors. Bioengineering & Translational Medicine. 2023;8(2). doi:10.1002/btm2.10439
BibTeX
@article{Hsiao2023,
author = {Hsiao, Ya-Chuan and Wang, I-Han and Yang, Tsung-Lin},
title = {Fibrotic remodeling and tissue regeneration mechanisms define the therapeutic potential of human muscular progenitors},
journal = {Bioengineering & Translational Medicine},
year = {2023},
volume = {8},
number = {2},
doi = {10.1002/btm2.10439}
}
EUVIMED